- Home
- RNAZ vs SBFM Comparison
RNAZ vs SBFM Comparison
Compare RNAZ & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- SBFM
- Stock Information
- Founded
- RNAZ 2016
- SBFM 2006
- Country
- RNAZ United States
- SBFM United States
- Employees
- RNAZ N/A
- SBFM N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- RNAZ Health Care
- SBFM Health Care
- Exchange
- RNAZ Nasdaq
- SBFM Nasdaq
- Market Cap
- RNAZ 6.1M
- SBFM 6.6M
- IPO Year
- RNAZ 2021
- SBFM N/A
- Fundamental
- Price
- RNAZ $11.36
- SBFM $1.47
- Analyst Decision
- RNAZ Strong Buy
- SBFM Strong Buy
- Analyst Count
- RNAZ 1
- SBFM 1
- Target Price
- RNAZ $280.00
- SBFM $15.00
- AVG Volume (30 Days)
- RNAZ 10.7K
- SBFM 43.5K
- Earning Date
- RNAZ 11-13-2025
- SBFM 11-04-2025
- Dividend Yield
- RNAZ N/A
- SBFM N/A
- EPS Growth
- RNAZ N/A
- SBFM N/A
- EPS
- RNAZ N/A
- SBFM N/A
- Revenue
- RNAZ N/A
- SBFM $36,341,741.00
- Revenue This Year
- RNAZ N/A
- SBFM $32.20
- Revenue Next Year
- RNAZ N/A
- SBFM $32.74
- P/E Ratio
- RNAZ N/A
- SBFM N/A
- Revenue Growth
- RNAZ N/A
- SBFM 19.22
- 52 Week Low
- RNAZ $6.15
- SBFM $1.17
- 52 Week High
- RNAZ $739.20
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- RNAZ 56.35
- SBFM 52.23
- Support Level
- RNAZ $10.67
- SBFM $1.45
- Resistance Level
- RNAZ $11.45
- SBFM $1.53
- Average True Range (ATR)
- RNAZ 0.61
- SBFM 0.06
- MACD
- RNAZ 0.10
- SBFM 0.01
- Stochastic Oscillator
- RNAZ 83.81
- SBFM 68.57
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.